HomeInsightsPE

Parmax Pharma Ltd PE Ratio

Parmax Pharma Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

3.4 K

stocks traded

Last Updated time: 04 Oct 14:03 PM

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

PE

0

Last updated: 04 Oct 14:03 PM

Key Highlights

  • The P/E Ratio of Parmax Pharma Ltd is 0 as of 04 Oct 14:03 PM.
  • The P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2019 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years. .
  • The Latest Trading Price of Parmax Pharma Ltd is ₹ 44 as of 04 Oct 13:47.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Parmax Pharma Ltd

No data available

Company Fundamentals for Parmax Pharma Ltd

No data available

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

PRICE

44

1.91 (4.54%)

stock direction

Last updated: 04 Oct 13:47

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Parmax Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
03 Oct 202442.09
01 Oct 202444.3
30 Sep 202446.63
27 Sep 202449.08
26 Sep 202451.66
25 Sep 202449.2
24 Sep 202446.87
23 Sep 202444.65
20 Sep 202444.1
19 Sep 202442.1

BlinkX Score for Parmax Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Parmax Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Parmax Pharma Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Parmax Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Parmax Pharma Ltd

No data available

* All values are in %

About Parmax Pharma Ltd

  • Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
  • The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
  • The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
  • The Company then discontinued their business activities for few years due to various reasons.
  • Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

Parmax Pharma Ltd News Hub

News

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Sep 202416:46

News

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

09 Aug 202414:53

News

Parmax Pharma revises board meeting date

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be ...

Read more

29 May 202412:10

News

Parmax Pharma schedules board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024 ...

Read more

24 May 202412:53

News

Parmax Pharma to hold board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

09 Feb 202416:10

News

Parmax Pharma announces board meeting date

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 10 November ...

Read more

07 Nov 202314:09

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Parmax Pharma Ltd

What is the current PE Ratio of Parmax Pharma Ltd?

The Current PE Ratio of Parmax Pharma Ltd is 0.0 as on 4 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 4 Oct 2024.

What was the PE Ratio of Parmax Pharma Ltd last year?

The PE Ratio of Parmax Pharma Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Parmax Pharma Ltd indicate about its stock?

The PE Ratio of Parmax Pharma Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Parmax Pharma Ltd.

What is the PE Ratio Growth of Parmax Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Parmax Pharma Ltd grew by -% whereas, the EPS ratio grew by -100.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*